Linked from

The 66 pages that link to Bioavailability, each with the reason it gives.

• CurcuminRelated: Curcumin’s low bioavailability complicates interpretation of its biological effects.

• NiclosamideRelated: Niclosamide is poorly absorbed from the intestine, helping limit systemic exposure during tapeworm treatment.

• Ellagic acidRelated: Low absorption and microbiome-dependent metabolism shape ellagic acid's availability.

• MedicationRelated: It helps explain why equal doses by different routes can have different effects.

• Metal toxicityRelated: Only bioavailable metal can readily enter organisms and contribute to internal exposure.

• QuercetinRelated: Absorption and metabolism determine how much ingested quercetin reaches the body.

• BerberineRelated: Berberine’s low oral bioavailability complicates dose selection and interpretation of clinical studies.

• Caffeic acidRelated: Only a portion of dietary caffeic acid is absorbed unchanged; metabolism alters exposure.

• EsomeprazoleRelated: Formulation and metabolism influence how much esomeprazole reaches the bloodstream.

• PharmaceuticsRelated: Formulation and route determine how much drug becomes available to the body.

• ResveratrolRelated: Low bioavailability constrains how much resveratrol can reach tissues after ingestion.

• SumatriptanRelated: Oral sumatriptan has limited bioavailability, while nonoral formulations bypass some absorption constraints.

• CiclosporinRelated: Ciclosporin absorption varies, and formulation affects how reliably it enters circulation.

• Environmental biotechnologyRelated: Contaminants bound to soil or sediment may resist biological treatment despite being present.

• Grifola frondosaRelated: How well maitake polysaccharides are absorbed or otherwise act in humans remains under study.

• Pharmaceutical preparationsRelated: Different preparations can deliver different fractions of the same dose.